Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Delirium severity and outcomes of critically ill COVID-19 patients.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Associação de Medicina Intensiva Brasileira Country of Publication: Brazil NLM ID: 9918627781706676 Publication Model: Print Cited Medium: Internet ISSN: 2965-2774 (Electronic) Linking ISSN: 29652774 NLM ISO Abbreviation: Crit Care Sci Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: São Paulo, SP, Brazil : Associação de Medicina Intensiva Brasileira, [2023]-
    • الموضوع:
    • نبذة مختصرة :
      Objective: To investigate the impact of delirium severity in critically ill COVID-19 patients and its association with outcomes.
      Methods: This prospective cohort study was performed in two tertiary intensive care units in Rio de Janeiro, Brazil. COVID-19 patients were evaluated daily during the first 7 days of intensive care unit stay using the Richmond Agitation Sedation Scale, Confusion Assessment Method for Intensive Care Unit (CAM-ICU) and Confusion Method Assessment for Intensive Care Unit-7 (CAM-ICU-7). Delirium severity was correlated with outcomes and one-year mortality.
      Results: Among the 277 COVID-19 patients included, delirium occurred in 101 (36.5%) during the first 7 days of intensive care unit stay, and it was associated with a higher length of intensive care unit stay in days (IQR 13 [7 - 25] versus 6 [4 - 12]; p < 0.001), higher hospital mortality (25.74% versus 5.11%; p < 0.001) and additional higher one-year mortality (5.3% versus 0.6%, p < 0.001). Delirium was classified by CAM-ICU-7 in terms of severity, and higher scores were associated with higher in-hospital mortality (17.86% versus 34.38% versus 38.46%, 95%CI, p value < 0.001). Severe delirium was associated with a higher risk of progression to coma (OR 7.1; 95%CI 1.9 - 31.0; p = 0.005) and to mechanical ventilation (OR 11.09; 95%CI 2.8 - 58.5; p = 0.002) in the multivariate analysis, adjusted by severity and frailty.
      Conclusion: In patients admitted with COVID-19 in the intensive care unit, delirium was an independent risk factor for the worst prognosis, including mortality. The delirium severity assessed by the CAM-ICU-7 during the first week in the intensive care unit was associated with poor outcomes, including progression to coma and to mechanical ventilation.
    • References:
      J Intensive Care Med. 2023 Aug;38(8):751-759. (PMID: 36939479)
      Crit Care Med. 2017 May;45(5):851-857. (PMID: 28263192)
      Crit Care Explor. 2020 Nov 25;2(12):e0290. (PMID: 33251519)
      Intensive Care Med. 2020 May;46(5):854-887. (PMID: 32222812)
      N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
      JAMA. 2001 Dec 5;286(21):2703-10. (PMID: 11730446)
      Lancet Respir Med. 2021 Mar;9(3):239-250. (PMID: 33428871)
      Crit Care. 2020 Jun 23;24(1):375. (PMID: 32576234)
      PLoS One. 2018 May 11;13(5):e0197226. (PMID: 29750814)
      Crit Care Med. 2001 Jul;29(7):1370-9. (PMID: 11445689)
      J Clin Med. 2021 Jul 02;10(13):. (PMID: 34279458)
      Arch Gerontol Geriatr. 2021 Jul-Aug;95:104388. (PMID: 33713880)
      Am J Respir Crit Care Med. 2002 Nov 15;166(10):1338-44. (PMID: 12421743)
      JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. (PMID: 32667669)
      Clin Microbiol Infect. 2021 Jan;27(1):47-54. (PMID: 33190794)
      Stat Med. 2017 Nov 30;36(27):4391-4400. (PMID: 28913837)
      Am J Crit Care. 2020 Jul 1;29(4):311-317. (PMID: 32607574)
      BMJ. 2015 Jun 03;350:h2538. (PMID: 26041151)
      J Chronic Dis. 1987;40(5):373-83. (PMID: 3558716)
      Neurohospitalist. 2022 Jan;12(1):31-37. (PMID: 34950384)
      Crit Care. 2020 Aug 8;24(1):491. (PMID: 32771053)
      Am J Respir Crit Care Med. 2009 Dec 1;180(11):1092-7. (PMID: 19745202)
      Intensive Care Med. 2022 Mar;48(3):366-368. (PMID: 35041016)
      Crit Care. 2018 May 5;22(1):114. (PMID: 29728150)
      J Trauma Acute Care Surg. 2012 Jun;72(6):1526-30; discussion 1530-1. (PMID: 22695416)
      N Engl J Med. 2020 Jun 4;382(23):2268-2270. (PMID: 32294339)
      PLoS One. 2019 Sep 25;14(9):e0222164. (PMID: 31553738)
      Neurocrit Care. 2022 Feb;36(1):89-96. (PMID: 34184176)
      Intern Emerg Med. 2021 Oct;16(7):1997-2000. (PMID: 33830418)
      Intensive Care Med. 2021 Oct;47(10):1089-1103. (PMID: 34401939)
      J Am Geriatr Soc. 2020 Nov;68(11):2440-2446. (PMID: 32835425)
      J Med Virol. 2021 Jul;93(7):4374-4381. (PMID: 33782993)
      Intensive Care Med. 1999 Jul;25(7):686-96. (PMID: 10470572)
      Intensive Care Med. 2021 Sep;47(9):943-960. (PMID: 34379152)
      Neurocrit Care. 2021 Dec;35(3):693-706. (PMID: 33725290)
      Crit Care. 2017 Jul 12;21(1):179. (PMID: 28697802)
      Intensive Care Med. 2015 Jun;41(6):1048-56. (PMID: 25894620)
      JAMA Neurol. 2020 Jun 1;77(6):683-690. (PMID: 32275288)
      Neurol Sci. 2021 Oct;42(10):3981-3988. (PMID: 34318364)
    • الموضوع:
      Date Created: 20240124 Date Completed: 20240125 Latest Revision: 20240127
    • الموضوع:
      20240127
    • الرقم المعرف:
      PMC10802771
    • الرقم المعرف:
      10.5935/2965-2774.20230170-en
    • الرقم المعرف:
      38265321